DK1024824T3 - Dispergerende vaccinesammensætning i fast form til oral indgivelse - Google Patents

Dispergerende vaccinesammensætning i fast form til oral indgivelse

Info

Publication number
DK1024824T3
DK1024824T3 DK98950200T DK98950200T DK1024824T3 DK 1024824 T3 DK1024824 T3 DK 1024824T3 DK 98950200 T DK98950200 T DK 98950200T DK 98950200 T DK98950200 T DK 98950200T DK 1024824 T3 DK1024824 T3 DK 1024824T3
Authority
DK
Denmark
Prior art keywords
vaccine composition
oral administration
solid form
form dispersing
dispersing
Prior art date
Application number
DK98950200T
Other languages
English (en)
Inventor
Harry Seager
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Application granted granted Critical
Publication of DK1024824T3 publication Critical patent/DK1024824T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
DK98950200T 1997-10-27 1998-10-27 Dispergerende vaccinesammensætning i fast form til oral indgivelse DK1024824T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722682.3A GB9722682D0 (en) 1997-10-27 1997-10-27 Pharmaceutical products

Publications (1)

Publication Number Publication Date
DK1024824T3 true DK1024824T3 (da) 2004-09-20

Family

ID=10821162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98950200T DK1024824T3 (da) 1997-10-27 1998-10-27 Dispergerende vaccinesammensætning i fast form til oral indgivelse

Country Status (10)

Country Link
EP (1) EP1024824B1 (da)
JP (1) JP2001521007A (da)
AT (1) ATE274919T1 (da)
AU (1) AU9635998A (da)
DE (1) DE69826019T2 (da)
DK (1) DK1024824T3 (da)
ES (1) ES2227885T3 (da)
GB (1) GB9722682D0 (da)
PT (1) PT1024824E (da)
WO (1) WO1999021579A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
HUP0202537A3 (en) 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
AU2004216559B2 (en) * 2003-02-28 2010-05-27 Alk-Abello A/S Dosage form having a saccharide matrix
WO2005004923A1 (ja) * 2003-07-10 2005-01-20 Kyowa Hakko Kogyo Co., Ltd. 錠剤およびその製造方法
CA2866501A1 (en) 2003-11-10 2005-05-26 Allergan, Inc. Pharmaceutical compositions including low dosages of desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
EP1933867A1 (en) 2005-10-04 2008-06-25 Alk-Abello A/S Solid vaccine formulation
DK2187926T3 (da) 2007-09-11 2012-04-02 Univ Koebenhavn Forebyggelse af diabetes ved administration af gliadin
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
US20120121645A1 (en) * 2009-07-17 2012-05-17 The Board Of Regents For Oklahoma State University Supralingual vaccines and applicators
GB201009273D0 (en) * 2010-06-03 2010-07-21 Glaxosmithkline Biolog Sa Novel vaccine
EP3095441B1 (en) * 2010-10-08 2020-12-02 R.P. Scherer Technologies, LLC Oral vaccine fast-dissolving dosage form using starch
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
US11523988B2 (en) * 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
EP0688205A1 (en) * 1993-03-11 1995-12-27 Secretech, Inc. Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery

Also Published As

Publication number Publication date
AU9635998A (en) 1999-05-17
JP2001521007A (ja) 2001-11-06
ATE274919T1 (de) 2004-09-15
WO1999021579A1 (en) 1999-05-06
ES2227885T3 (es) 2005-04-01
DE69826019T2 (de) 2005-09-15
EP1024824A1 (en) 2000-08-09
GB9722682D0 (en) 1997-12-24
EP1024824B1 (en) 2004-09-01
DE69826019D1 (de) 2004-10-07
PT1024824E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
DE69826019D1 (de) Feste dispergierende impfstoffe-zusammensetzung zur oralen verabreichung
NO20015073D0 (no) Vaksiner
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
LU91328I2 (fr) Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé)
DZ2462A1 (fr) Vaccin antigrippal.
GB0025577D0 (en) Vaccine
DE60012042D1 (de) Entepneumovirus und entsprechendes impfstoff
ATE413188T1 (de) Menschliche papillomavirus impfstoff- formulierungen
DK1404363T3 (da) Adjuvanssammensætning til mucosalt og injektionsfremførte vacciner
NO20030713D0 (no) Oral faststoffdose vaksine
DK1259259T3 (da) Mucosal adjuvansformulering
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
NO972219D0 (no) Immunogenpreparater
ATE182270T1 (de) Mukosale verabreichung von pneumokokken-antigenen
BR9815404A (pt) Composição adjuvante para estimular uma eficiente resposta imunológica a uma substância antigênica, vacina para administração a um animal, processo para estimular uma resposta imunológica eficaz em um animal a uma substância antigênica, e, uso da composição adjuvante.
MY127452A (en) Vaccines.
MY128929A (en) Vaccine against hepatitis a and hepatitis b
HUP0400495A3 (en) Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue
IT1277926B1 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
RU96116250A (ru) Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
ES2102836T3 (es) El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.
DE50307169D1 (de) ORALE VAKZINIERUNG MIT DEM TUMOR-ANTIGEN-MIMOTOP Gln-Met-Trp-Ala-Pro-Gln-Trp-Gly-Pro-Asp
GT198500078A (es) Vacuna polivalente inmuno-estimulante